Hansen buys AorTx
This article was originally published in The Gray Sheet
Robotic catheter placement system maker Hansen Medical acquires "early stage" percutaneous aortic heart valve replacement device developer AorTx for $10 mil up front and up to $30 million in additional milestone payments. Announced Nov. 1, the cash and stock deal will allow Hansen to develop robotic catheter solutions for heart valve therapy, the company says. Hansen's Sensei robotic catheter placement system is currently marketed for electrophysiology procedures (1"The Gray Sheet" May 14, 2007, p. 15)
You may also be interested in...
An earlier-than-expected 510(k) clearance for Hansen Medical's Sensei robotic catheter placement system set the stage for an official launch at the May 9-12 Heart Rhythm Society Annual Scientific Sessions in Denver
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.